Lazard Asset Management LLC Xencor Inc Transaction History

Lazard Asset Management LLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$16.53 - $21.42 $3,487 - $4,519	211 Added 3.12%	6,967 $147,000
Q3 2023 Nov 14, 2023	BUY	$20.08 - $25.39 $135,660 - $171,534	6,756 New	6,756 $136,000
Q1 2023 May 15, 2023	SELL	$25.95 - $36.95 $65,705 - $93,557	-2,532 Reduced 89.25%	305 $8,000
Q4 2022 Feb 14, 2023	SELL	$24.79 - $30.86 $50,645 - $63,046	-2,043 Reduced 41.86%	2,837 $73,000
Q3 2022 Nov 14, 2022	BUY	$24.62 - $32.44 $7,755 - $10,218	315 Added 6.9%	4,880 $126,000
Q2 2022 Aug 09, 2022	BUY	$19.74 - $29.01 $1,579 - $2,320	80 Added 1.78%	4,565 $124,000
Q1 2022 May 13, 2022	BUY	$26.68 - $41.63 $80,173 - $125,098	3,005 Added 203.04%	4,485 $119,000
Q4 2021 Feb 09, 2022	SELL	$33.67 - $43.44 $817,103 - $1.05 Million	-24,268 Reduced 94.25%	1,480 $58,000
Q3 2021 Nov 15, 2021	BUY	$30.65 - $35.68 $732,994 - $853,287	23,915 Added 1304.69%	25,748 $840,000
Q2 2021 Aug 12, 2021	BUY	$34.33 - $44.68 $18,915 - $24,618	551 Added 42.98%	1,833 $62,000
Q1 2021 May 14, 2021	BUY	$40.81 - $53.88 $50,808 - $67,080	1,245 Added 3364.86%	1,282 $55,000
Q4 2020 Feb 11, 2021	BUY	$36.63 - $47.63 $1,355 - $1,762	37 New	37 $1,000
Q1 2020 May 14, 2020	SELL	$20.69 - $37.79 $13,117 - $23,958	-634 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$32.75 - $41.43 $6,681 - $8,451	204 Added 47.44%	634 $21,000
Q3 2019 Nov 14, 2019	BUY	$33.73 - $46.27 $14,503 - $19,896	430 New	430 $14,000

215

71.5M

2.5K

7.9K

Ticker XNCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,698,100
Market Cap $1.44B
Description
Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Lazard Asset Management LLC with notifications on news.